Welcome to our dedicated page for Nu Skin Enter SEC filings (Ticker: NUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nu Skin Enterprises, Inc. (NYSE: NUS) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its integrated beauty and wellness operations. These SEC filings cover the performance of the Nu Skin and Rhyz businesses, including revenue, margins, segment results and key metrics such as Customers, Paid Affiliates and Sales Leaders in the core Nu Skin business.
Among the most important filings for NUS are its annual reports on Form 10-K, which describe the company’s business model, risk factors, segment structure, accounting policies and long-term trends, and its quarterly reports on Form 10-Q, which update investors on interim financial performance and regional results. Nu Skin also uses Form 8-K to report material events, such as the release of quarterly and year-to-date financial results, including revenue, earnings per share, non-GAAP measures like constant-currency revenue change and adjusted EPS, and commentary on operating conditions.
In addition, investors can review proxy statements for information on governance and executive compensation, and Form 4 filings to track insider transactions by directors and officers. These documents help clarify how Nu Skin’s leadership and affiliate-driven model align with shareholder interests.
On this page, Stock Titan provides real-time access to Nu Skin’s latest SEC filings as they are posted to EDGAR, along with AI-powered summaries that explain the key points in clear language. Instead of reading entire multi-hundred-page 10-Ks or detailed 10-Qs, you can use these summaries to understand segment performance, changes in margins, updates on initiatives such as Prysm iO and regional expansion, and other material disclosures. Filings related to non-GAAP measures, restructuring and gains or losses from business sales are also highlighted so you can see how they affect reported results.
NU SKIN ENTERPRISES, INC. Chief Financial Officer Thomas James D received a grant of 114,706 shares of Class A Common Stock on March 6, 2026. The shares were awarded at a price of $0.00 per share, reflecting a stock grant rather than an open-market purchase.
Following this award, his directly held Class A Common Stock position increased to 267,102 shares. The transaction is coded as a grant, award, or other acquisition, indicating it was part of an equity award arrangement rather than a cash-funded transaction.
NU SKIN ENTERPRISES, INC. President and CEO Ryan S. Napierski reported receiving an equity grant of 282,353 shares of Class A Common Stock on March 6, 2026. The shares were acquired as a grant or award at a reported price of $0.00 per share. Following this award, his directly held stake increased to 1,001,905 Class A shares.
Nu Skin Enterprises appointed Chayce D. Clark as Executive Vice President, Chief Operating Officer and Chief Legal Officer. Clark has been the company’s Executive Vice President and General Counsel since 2021 after joining Nu Skin in 2015 and holding several senior legal roles.
In his expanded role, he will oversee revenue performance and end-to-end operational execution, including global sales, product innovation, technology platforms, global programs, brand initiatives and legal services across nearly 50 markets. His base salary is $650,000, with a target annual bonus of 75% of base salary.
Clark’s 2026 annual equity award is valued at $2,362,500, split evenly between time-based RSUs and performance-based RSUs. The RSUs vest 25% in each of 2027–2030, while the PRSUs vest in three tranches based on earnings per share performance in 2026, 2027 and 2028.
Nu Skin Enterprises executive Justin S. Keisel reported a tax-related share disposition. On February 26, 2026, 13,687 shares of Nu Skin Class A common stock were withheld at $8.63 per share to cover tax obligations from the vesting of previously granted restricted stock units.
After this non-open-market, tax-withholding disposition, Keisel’s direct holdings totaled 113,111 shares of Class A common stock. This type of transaction is administrative and tied to equity compensation rather than a discretionary share sale.
Nu Skin Enterprises Chief Product Officer Steven Keith Hatchett had 26,001 shares of Class A common stock withheld on February 26, 2026 to cover tax obligations tied to vesting restricted stock units. These were recorded at $8.63 per share, leaving him with 182,877 shares held directly.
Nu Skin Enterprises EVP and General Counsel Chayce David Clark reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 45,502 shares of Class A common stock were withheld at $8.63 per share to cover tax obligations. After this non‑open‑market withholding, Clark directly holds 251,775 shares of Nu Skin Enterprises Class A common stock.
Nu Skin Enterprises Chief Financial Officer Thomas James reported a Form 4 transaction involving Class A Common Stock. On February 26, 2026, 28,602 shares were disposed of at $8.63 per share through shares being withheld to cover tax obligations on previously vested restricted stock units. After this tax-withholding disposition, he directly held 152,396 shares of Nu Skin Enterprises Class A Common Stock.
Nu Skin Enterprises President and CEO Ryan S. Napierski reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 124,802 shares of Class A common stock were withheld at $8.63 per share to satisfy tax withholding obligations. After this non-market, tax-withholding disposition, he directly holds 719,552 shares of Nu Skin Class A common stock.
NU SKIN ENTERPRISES, INC. executive Justin S. Keisel reported a tax-related share disposition tied to equity compensation. On this Form 4, 1,534 shares of Class A Common Stock were withheld at $8.36 per share to cover tax obligations from vesting restricted stock units. After this non‑open‑market tax-withholding transaction, Keisel directly held 126,798 shares.
Nu Skin Enterprises Chief Product Officer Steven Keith Hatchett reported a tax-withholding disposition of 10,763 shares of Class A common stock at $8.36 per share. These shares were withheld to cover tax obligations related to vesting restricted stock units. After this transaction, he directly holds 208,878 shares.